3CHI yesterday announced the successful development and scalable production of highly pure 11-Hydroxy-THC, or 11-OH-THC, marking a milestone backed by two years of relentless R&D and a multi-million-dollar investment.
"This milestone underscores 3CHI's industry dominance, where our unrivaled cannabinoid science turns claims into reality, be it compliant ∆8-THC vape products, accurate testing or authentic 11-Hydroxy-THC products,' says CEO Justin Journay, in a statement.
According to the company, Journay's false claims reference comes as competitors have been selling products falsely labeled as 11-Hydroxy-THC products and the vast majority of competitors continue to sell vape products with non-compliant levels of ∆9-THC through the help of cannabis testing labs giving inaccurate results, possibly on purpose.
The 11-Hydroxy-THC metabolite, which has the unique effects associated with orally consumed THC, is now available in vapor form. Vaping 11-Hydroxy-THC is expected to deliver the distinctive edible effects in a fraction of the time.
3CHI's hemp-derived synthesis and production of 11-Hydroxy-THC showcases purity levels between 95-99%, with the remainder being other cannabinoids.
After pioneering this specific 11-OH-∆8-THC variant, 3CHI plans to launch the ∆9 variant soon.
